BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3349146)

  • 1. [Changes in the antioxidative activity and phospholipid composition of the erythrocytes in neurosis patients as affected by fenazepam].
    Kaipova GD; Burlakova EB; Molochkina EM; Neznamov GG; Poiurovskiĭ MV
    Biull Eksp Biol Med; 1988 Feb; 105(2):171-3. PubMed ID: 3349146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinicobiochemical parallels in borderline neuropsychic disorders].
    Ushakov GK; Maslova AF; Kostiunina ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1663-6. PubMed ID: 6119860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level].
    Neznamov GG; Morozov IS; Barchukov VG; Teleshova ES; Siuniakov SA; Zhirov EN; Tkachev AE; Belyĭ IuN; Kolotilinskaia NV; Safarova TP; Barannikov AS; Chernyĭ AV; Shestopalov SS
    Eksp Klin Farmakol; 1997; 60(4):17-21. PubMed ID: 9376749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of the clinical pharmacological action of a single dose of fenazepam with the EEG dynamics and pharmacokinetics].
    Uvarova LG; Zherdev VP; Neznamov GG; Khrulenko-Varnitskiĭ IO; Sigunova EA
    Farmakol Toksikol; 1986; 49(1):66-9. PubMed ID: 2868919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of changes in the antioxidative activity and phospholipid composition of the rat liver in the mechanism of phenazepam action on the liver and the protective effect of talamonal].
    Molochkina EM; Kaipova GD; Papin AA; Korotkina RN; Karelin AA
    Vopr Med Khim; 1985; 31(3):17-21. PubMed ID: 4024526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of bemitil pharmacokinetics in realizing its therapeutic efficacy].
    Boĭko SS; Zherdev VP; Neznamov GG
    Farmakol Toksikol; 1991; 54(2):64-6. PubMed ID: 1679400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the anti-alcohol action of fenazepam].
    Otkalenko AK; Pentiuk AA; Barkov NK
    Farmakol Toksikol; 1987; 50(1):104-7. PubMed ID: 3556543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI; Marshak OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):90-8. PubMed ID: 2907706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of tranquilizers on lipid peroxidation of biological membranes].
    Kudrin AN; Smolenskiĭ VS; Khusainov VM; Abinder AA; Luk'ianova LL
    Farmakol Toksikol; 1987; 50(1):14-7. PubMed ID: 3104081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacokinetic aspects of the clinical action of gidazepam].
    Zherdev VP; Neznamov GG; Kolyvanov GB; Litvin AA; Otabekova SG
    Eksp Klin Farmakol; 1993; 56(3):50-2. PubMed ID: 8106055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in using fenazepam to treat psychotic patients].
    Nuller IuL; Tochilov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):914-20. PubMed ID: 6106340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenazepam in the treatment of borderline forms of neuropsychiatric disorders].
    Kalandarishvili AS; Bortnik TL; Berdina ES; Lesovskaia TV; Aleksandrovskiĭ IuA
    Sov Med; 1979 Jul; (7):8-14. PubMed ID: 41325
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neurological complications following therapy with tranquilizers and their drug correction].
    Ben'kovich BI
    Sov Med; 1983; (7):86-9. PubMed ID: 6623185
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of tranquilizers on critical flicker fusion frequency in the visual system.
    Ben'kovich BI; Marshak OV
    Hum Physiol; 1984; 10(6):435-9. PubMed ID: 6544738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relation between the dynamics of EEG indices after a single dose of the tranquilizer phenazepam and its efficacy during a course of treatment of patients with borderline neuropsychological disorders].
    Uvarova LG; Titaeva MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1701-9. PubMed ID: 4082841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation of the electroencephalographic and clinical effects of benzodiazepine tranquilizers in patients with mental disorders at the neurotic level].
    Bochkarev VK; Neznamov GG
    Eksp Klin Farmakol; 1995; 58(4):18-22. PubMed ID: 7580745
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term (12 months) tolerance to Loprazolam (Ru 31.158) in patients affected with insomnia].
    Costa e Silva JA; Borges RS
    Ann Med Psychol (Paris); 1982 Dec; 140(10):1114-21. PubMed ID: 6137177
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intensity of lipid peroxidation and its relation to changes in the composition and antioxidative properties of lipids in acute viral hepatitis].
    Bliuger AF; Dudnik LB; Maĭore AIa; Nozdrunova NA; Mieze IE
    Vopr Med Khim; 1985; 31(5):35-7. PubMed ID: 4090364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.